Cases 1 - 10 of 36
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. ALVOGEN, INC.
as 2:2023cv03911
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM INTERNATIONAL GMBH and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Defendant:
ALVOGEN, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. ALVOGEN, INC.
as 3:2023cv03911
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM INTERNATIONAL GMBH and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Defendant:
ALVOGEN, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. ANOBRI PHARMACEUTICALS US, LLC et al
as 2:2023cv03530
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
ANOBRI PHARMACEUTICALS US, LLC, NANCHANG ANOVENT PHARMACEUTICAL CO., LTD. and SHANGHAI ANOVENT PHARMACEUTICAL CO., LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. ANOBRI PHARMACEUTICALS US, LLC et al
as 2:2023cv03531
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
ANOBRI PHARMACEUTICALS US, LLC, NANCHANG ANOVENT PHARMACEUTICAL CO., LTD. and SHANGHAI ANOVENT PHARMACEUTICAL CO., LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. QILU PHARMACEUTICAL CO., LTD. et al
as 3:2021cv01732
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
QILU PHARMACEUTICAL CO., LTD. and QILU PHARMA INC.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG et al v. AUROBINDO PHARMA LIMITED et al
as 3:2019cv08840
Plaintiff:
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LIMITED
Cause Of Action: 15 U.S.C. § 1126
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. LUPIN ATLANTIS HOLDINGS SA et al
as 3:2018cv12663
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
LUPIN LIMITED and LUPIN ATLANTIS HOLDINGS SA
Cause Of Action: 15 U.S.C. § 1126
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. LUPIN ATLANTIS HOLDING SA et al
as 3:2018cv12662
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM INTERNATIONAL GMBH and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Defendant:
LUPIN ATLANTIS HOLDING SA and LUPIN LIMITED
Cause Of Action: 15 U.S.C. § 1126
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. APOTEX INC. et al
as 3:2018cv11350
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
APOTEX CORP. and APOTEX INC.
Cause Of Action: 15 U.S.C. § 1126
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. FRESENIUS KABI USA, LLC et al
as 3:2018cv03244
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. , BOEHRINGER INGELHEIM INTERNATIONAL GMBH and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Defendant:
FRESENIUS KABI USA, LLC and FRESENIUS KABI ONCOLOGY LTD.
Counter_claimant:
FRESENIUS KABI USA, LLC and FRESENIUS KABI ONCOLOGY LTD.
Counter_defendant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH , BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Cause Of Action: 15 U.S.C. § 1126
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
